Work

Pharmacokinetic- and Pharmacodynamic-Guided Phase 1 Study of an Oral Fixed-Dose Combination of Decitabine and the Cytidine Deaminase Inhibitor Cedazuridine in Myelodysplastic Syndromes

Year: 2018

Type: preprint

Study design: Clinical Trial

Source: SSRN Electronic Journal

DOI: 10.2139/ssrn.3287512

Authors: Michael Savona, Olatoyosi Odenike, Philip C. Amrein, David P. Steensma, Amy E. DeZern, Laura C. Michaelis, Stefan Faderl, Wael Harb, Hagop Kantarjian, James Lowder, Aram Oganesian, Mohammad Azab, Guillermo Garcia-Manero

Institutions: Vanderbilt University, Vanderbilt-Ingram Cancer Center, University of Chicago Medical Center, Harvard University, Massachusetts General Hospital, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Johns Hopkins University, Johns Hopkins Hospital, Medical College of Wisconsin, Rutgers, The State University of New Jersey, Hackensack University Medical Center, Horizon Oncology Center, Astex Pharmaceuticals

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W3123807920

Cites:

Cited by: 1

Related to: 10